Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

April Armstrong

Showing results (1-10 of 124) with videos related to

Pageof 13
Sort By:
Hand Clinics|October 27, 2015
Simple Elbow DislocationApril Armstrong
The Medical Clinics of North America|July 5, 2014
Evaluation and management of adult shoulder pain: a focus on rotator cuff disorders, acromioclavicular joint arthritis, and glenohumeral arthritisApril Armstrong
Journal of Drugs in Dermatology : JDD|December 15, 2017
Real-World Clinical Experience With Apremilast in a Large US Retrospective Cohort Study of Patients With Moderate to Severe Plaque PsoriasisApril Armstrong, Eugenia Levi
Hand Clinics|February 27, 2008
Chronically unreduced elbow dislocationsRobert P Lyons, April Armstrong
The Journal of Clinical and Aesthetic Dermatology|April 26, 2017
The Role of IL-17 in the Pathogenesis and Treatment of PsoriasisJoshua A Zeichner, April Armstrong
JB & JS Open Access|June 5, 2023
The More Things Change, the More They Stay the Same: Residents Perspectives on Learning to Teach Over 7 YearsSandra Jarvis-Selinger, April Armstrong, Katherine Wisener
Plos One|May 3, 2011
Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985-2010Balvinder Rehal, April W Armstrong, April Armstrong
Journal of Drugs in Dermatology : JDD|April 7, 2022
SUPPLEMENT ARTICLE: A Novel Drug Delivery Method: Retrometabolic Drug DesignApril Armstrong, Rasika Reddy, Deepak Chadha, et al.
Dermatology and Therapy|September 19, 2025
Brodalumab as a Second-Line Therapy in Psoriasis: Rapid Response and Unique Mechanism of Action After Biologic FailureLawrence Green, April Armstrong, George Han, et al.
Journal of Drugs in Dermatology : JDD|February 5, 2026
INDIVIDUAL ARTICLE: Evidence-Based Synthesis of Deucravacitinib: Long Term Efficacy, Safety, and Practical Use in Moderate-to-Severe PsoriasisAbigail Katz, Charles Kircik, Angela Lamb, et al.
Pageof 13

Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
Hand Clinics|October 27, 2015
Simple Elbow DislocationApril Armstrong
The Medical Clinics of North America|July 5, 2014
Evaluation and management of adult shoulder pain: a focus on rotator cuff disorders, acromioclavicular joint arthritis, and glenohumeral arthritisApril Armstrong
Journal of Drugs in Dermatology : JDD|December 15, 2017
Real-World Clinical Experience With Apremilast in a Large US Retrospective Cohort Study of Patients With Moderate to Severe Plaque PsoriasisApril Armstrong, Eugenia Levi
Hand Clinics|February 27, 2008
Chronically unreduced elbow dislocationsRobert P Lyons, April Armstrong
The Journal of Clinical and Aesthetic Dermatology|April 26, 2017
The Role of IL-17 in the Pathogenesis and Treatment of PsoriasisJoshua A Zeichner, April Armstrong
JB & JS Open Access|June 5, 2023
The More Things Change, the More They Stay the Same: Residents Perspectives on Learning to Teach Over 7 YearsSandra Jarvis-Selinger, April Armstrong, Katherine Wisener
Plos One|May 3, 2011
Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985-2010Balvinder Rehal, April W Armstrong, April Armstrong
Journal of Drugs in Dermatology : JDD|April 7, 2022
SUPPLEMENT ARTICLE: A Novel Drug Delivery Method: Retrometabolic Drug DesignApril Armstrong, Rasika Reddy, Deepak Chadha, et al.
Dermatology and Therapy|September 19, 2025
Brodalumab as a Second-Line Therapy in Psoriasis: Rapid Response and Unique Mechanism of Action After Biologic FailureLawrence Green, April Armstrong, George Han, et al.
Journal of Drugs in Dermatology : JDD|February 5, 2026
INDIVIDUAL ARTICLE: Evidence-Based Synthesis of Deucravacitinib: Long Term Efficacy, Safety, and Practical Use in Moderate-to-Severe PsoriasisAbigail Katz, Charles Kircik, Angela Lamb, et al.
Pageof 13